A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Scientists have successfully grown over 400 different types of nerve cells from stem cells in the lab—a groundbreaking step ...

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the population ages. These conditions cause brain cells to break down over time, ...

A new initiative is set to explore the potential of repurposing existing medications to combat the symptoms of both Alzheimer’s and Parkinson’s diseases, aiming to accelerate the discovery of novel ...